Glaukos (GKOS) Other Non Operating Income (2014 - 2026)
Glaukos' (GKOS) quarterly Other Non Operating Income came in at -$749000.0 in Q1 2026, down 179.26% year-on-year from $945000.0 in Q1 2025, and down 113.41% on a QoQ basis from $5.6 million in Q4 2025.
Glaukos (GKOS) Other Non Operating Income (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has 9 years of Other Non Operating Income data on file, last reported at -$749000.0 in Q1 2026.
- On a quarterly basis, Other Non Operating Income fell 179.26% year-over-year to -$749000.0 in Q1 2026; TTM through Mar 2026 was $5.7 million, a 131.6% increase from a year earlier, with the FY2025 full-year figure at $7.4 million, up 136.96% from the prior year.
- Other Non Operating Income for Q1 2026 stood at -$749000.0, down from $5.6 million in the prior quarter.
- Over the last five years, Other Non Operating Income for GKOS reached as high as $9.0 million in Q4 2023 and fell as low as -$19.6 million in Q4 2024.
- Historically, Other Non Operating Income has averaged -$545818.2 across 4 years, with a median of -$749000.0 in 2026.
- On a YoY basis, Other Non Operating Income climbed as much as 239.91% in 2024 and fell as far as 317.13% in 2024.
- Year by year, Other Non Operating Income stood at $9.0 million in 2023, then tumbled by 317.13% to -$19.6 million in 2024, then jumped by 128.46% to $5.6 million in 2025, then plunged by 113.41% to -$749000.0 in 2026.
- Per Business Quant data, the three most recent Other Non Operating Income figures were -$749000.0 in Q1 2026, $5.6 million in Q4 2025, and -$1.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Glaukos | 8.83 Bn | 8.73 Bn | 117.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -749,000.00 |
| Dec 31, 2025 | 5.58 Mn |
| Sep 30, 2025 | -1.01 Mn |
| Jun 30, 2025 | 1.86 Mn |
| Mar 31, 2025 | 945,000.00 |
| Dec 31, 2024 | -19.62 Mn |
| Sep 30, 2024 | 2.39 Mn |
| Jun 30, 2024 | -1.70 Mn |
| Mar 31, 2024 | -1.03 Mn |
| Dec 31, 2023 | 9.04 Mn |
| Sep 30, 2023 | -1.71 Mn |
| Dec 31, 2018 | -4.66 Mn |
| Sep 30, 2018 | -230,000.00 |
| Dec 31, 2017 | 437,000.00 |
| Sep 30, 2017 | 295,000.00 |
| Jun 30, 2017 | 586,000.00 |
| Mar 31, 2017 | 629,000.00 |
| Dec 31, 2016 | -431,000.00 |
| Sep 30, 2016 | 269,000.00 |
| Jun 30, 2016 | 210,000.00 |